DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer

Molecular Cancer Therapeutics

Volumn 2, Issue 12, 2003, Pages 1257-1264

  Kashishian, Adam ^a   Douangpanya, Heather ^a   Clark, Darcey ^a   Schlachter, Stephen T ^b   Eary, C Todd ^b   Schiro, Justin G ^b   Huang, Hongmei ^b   Burgess, Larry E ^b   Kesicki, Edward A ^a   Halbrook, James ^a  

^a ELI LILLY AND COMPANY   (United States)

^b ARRAY BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; DNA DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; NUCLEAR PROTEIN; PRKDC PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; DNA DAMAGE; DRUG ANTAGONISM; HELA CELL; HUMAN; MOUSE; NUDE MOUSE; PHENOTYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA DAMAGE; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HELA CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES;

EID: 2642567204     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baumann, P. and West, S. C. DNA end-joining catalyzed by human cell-free extracts. Proc. Natl. Acad. Sci. USA, 95: 14066-14070, 1998. (Pubitemid 28549321)
2. Critchlow, S. E. and Jackson, S. P. DNA end-joining: from yeast to man. Trends Biochem. Sci., 23: 394-398, 1998. (Pubitemid 28511380)
3. Dvir, A., Peterson, S. R., Knuth, M. W., Lu, H., and Dynan, W. S. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc. Natl. Acad. Sci. USA, 89: 11920-11924, 1992. (Pubitemid 23004756)
4. Gottlieb, T. M. and Jackson, S. P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell, 72: 131-142, 1993. (Pubitemid 23029700)
5. Fulop, G. M. and Phillips, R. A. The scid mutation in mice causes a general defect in DNA repair. Nature, 347: 479-482, 1990.
6. Biedermann, K. A., Sun, J., Giaccia, A. J., Tosto, L. M., and Brown, M. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc. Natl. Acad. Sci. USA, 88: 1394-1397, 1991. (Pubitemid 21916230)
7. Hendrickson, E. A., Qin, X-Q., Bump, E. A., Schatz, D. G., Oettinger, M., and Weaver, D. T. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proc. Natl. Acad. Sci. USA, 88: 4061-4065, 1991. (Pubitemid 21914478)
8. Kurimasa, A., Ouyang, H., Dong, L-J., Wang, S., Li, X., Cordon-Cardo, C., Chen, D. J., and Li, G. C. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc. Natl. Acad. Sci. USA, 96: 1403-1408, 1999. (Pubitemid 29098463)
9. Hanson, J. R. The viridian family of steroidal antibiotics. Nat. Prod. Rep., 12: 381-384, 1995.
10. Izzard, R. A., Jackson, S. P., and Smith, G. C. M. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer. Res., 59: 2581-2586, 1999. (Pubitemid 29269102)
11. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
12. Price, B. D. and Youmell, M. B. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res., 56: 246-250, 1996. (Pubitemid 26026348)
13. Boulton, S., Kyle, S., Yalcintepe, L., and Durkacz, B. W. Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis, 17: 2285-2290, 1997. (Pubitemid 26402223)
14. Rosenzweig, K. E., Youmell, B. B., Palayoor, S. T., and Price, B. D. Radiosensitization of human tumor cells by the phosphatidylinositol 3-kinase inhibitors wortmannin and LY204002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin. CancerRes., 3: 1149-1156, 1997. (Pubitemid 27319761)
15. Hosoi, Y., Miyachi, H., Matsumoto, Y., Ikehata, H., Komura, J-I., Ishii, K., Zhao, H-J., Yoshida, M., Tadai, Y., Yamada, S., Suzuki, N., and Ono, T. A phosphatidylinositol 3-kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation. Int. J. Cancer, 78: 642-647, 1998. (Pubitemid 28507191)
16. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., and Grindey, G. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res., 54: 2419-2423, 1994.
17. Arcaro, A. and Wymann, M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J., 296: 297-301, 1993. (Pubitemid 23350826)
18. Jhappan, C., Morse III, H. C., Fleischmann, R. D., Gottesman, M. M., and Merlino, G. DNA-PKcs: a T-cell tumor suppressor encoded at the mouse scid locus. Nat. Genet., 17: 483-486, 1997. (Pubitemid 27518403)
19. Gao, Y., Chaudhuri, J., Zhu, C., Davidson, L., Weaver, D. T., and Alt, F. W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity, 9: 367-376, 1998. (Pubitemid 28462757)
20. Taccioli, G. E., Amatucci, A. G., Beamish, H. J., Gell, D., Xiang, X. H., Torres Arzayus, M. I., Priestley, A., Jackson, S. P., Marshak Rothstein, A., Jeggo, P. A., and Herrera, V. L. M. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity, 9: 355-366, 1998. (Pubitemid 28462756)
21. Bosma, M. J. and Carroll, A. M. The scid mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol., 9: 323-350, 1991.
22. Peterson, S. R., Kurimasa, A., Oshimura, M., Dynan, W. S., Bradbury, E. M., and Chen, D. J. Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc. Natl. Acad. Sci. USA, 92: 10285-10290, 1995.
23. Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., and Jackson, S. P. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell, 80: 813-823, 1995.
24. Lees-Miller, S. P., Chen, Y-R., and Anderson, C. W. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell. Biol., 10: 6472-6481, 1990. (Pubitemid 120004591)
25. Sadhu, C., Masinovsky, B., Dick, K., Sowell, C. G., and Stanton, D. E. Essential role of phosphoinositide 3-kinase y in neutrophil directional movement. J. Immunol., 170: 2647-2654, 2003. (Pubitemid 36245657)
26. Corbett, T., Valeriote, F., LoRusso, P., Polin, L., Panchapor, C., Pugh, S., White, K., Knight, J., Demchik, L., Jones, J., Jones, L., and Lisow, L. In vivo methods for screening and preclinical testing. In: B. A. Teicher (ed.), Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, pp. 75-99. Totowa, NJ: Humana Press, 1997.
27. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. The protein kinase complement of the human genome. Science, 298: 1912-1934, 2002. (Pubitemid 35425239)
28. Hartley, K. O., Gell, D., Smith, G. C., Zhang, H., Divecha. N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82: 849-856, 1995.
29. Poltoratsky, V. P., Shi, X., York, J. D., Lieber, M. R., and Carter, T. H. Human DNA-activated protein kinase (DNA-PK) is homologous to phosphatidylinositol kinases. J. Immunol., 155: 4529-4533, 1995.
30. Hall, E. J. Radiobiology for the Radiobiologist (4th ed.), pp. 29-43. Philadelphia: J. B. Lippincott Co., 1994.
31. Wozniak, A. J. and Ross W. E. DNA damage as a basis for 4′-demethylepipodophyllotoxin- 9-(4,6-O -ethylidene-β-D- glucopyranoside) (etoposide) cytotoxicity. Cancer Res., 43: 120-124, 1983. (Pubitemid 13172805)
32. Long, B. H., Musial, S. F., and Brattain, M. G. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res., 45: 3106-3112, 1985. (Pubitemid 15007180)
33. Stubbe, J. and Kozarich, J. W. Mechanisms of bleomycin-induced DNA degradation. Chem Rev., 87: 1107-1136, 1987.
34. Lees-Miller, S. P, Godbout, R., Chan, D. W., Weinfeld, M., Day III, R. S., Barron, G. M., and Allalunis-Turner, J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science, 267: 1183-1185, 1995.
35. Shao, R-G., Cao, C-X., Zhang, H., Kohn, K. W., Wold, M. S., and Pommier, Y. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J., 18: 1397-1406, 1999. (Pubitemid 29110323)
36. Coleman, N. C. Radiation and chemotherapy sensitizers and protectors. In: B. A. Chabner and D. L. Longo (eds.), Cancer Chemotherapy and Biotherapy, 2nd ed., pp. 553-584. Philadelphia: Lippincott-Raven, 1996.
37. Strumberg, D., Pilon, A. A., Smith, M., Hickey, R., Malkas, L., and Pommier, Y. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5V-phosphorylated DNA double-strandbreaks by replication runoff. Mol. Cell. Biol., 20: 3977-3987, 2000. (Pubitemid 30314496)
38. Arnaudeau, C. Lundin, C., and Helleday, T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J. Mol. Biol., 307: 1235-1245, 2001. (Pubitemid 33027636)
39. Piret, B., Schoonbroodt, S., and Piette, J. The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene, 18: 2261-2271, 1999. (Pubitemid 29186927)
40. Wang, Y., Zhou, Z-Z., Wang, H. Huq, S., and Illiakis, G. Roles of replication protein A and DNA-dependent protein kinase in the regulation of DNA replication following DNA damage. J. Biol. Chem., 274: 22060-22064, 1999.